Am J Pathol

1. PELLOWE AS, Wu MJ, Kang TY, Chung TD, et al
   TGF-beta1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease.
   Am J Pathol. 2024;194:1171-1184.
   

   >> Share

   
   

   
   Ann Intern Med

2. NWABUDIKE LC
   Efficacy of Acupuncture for Chronic Spontaneous Urticaria.
   Ann Intern Med. 2024;177:838.
   

   >> Share

   
   
3. LI Y, Zheng H, Xiao XJ, Shi YZ, et al
   Efficacy of Acupuncture for Chronic Spontaneous Urticaria.
   Ann Intern Med. 2024;177:838-839.
   

   >> Share

   
   
4. DENIS G, Espitia O, Allix-Beguec C, Dieval C, et al
   Diagnostic Strategy Using Color Doppler Ultrasound of Temporal Arteries in Patients With High Clinical Suspicion of Giant Cell Arteritis : A Prospective Cohort Study.
   Ann Intern Med. 2024;177:729-737.
   

   >> Share

   
   

   
   BMC Cancer

5. MASHAYEKH-AMIRI S, Jafarabadi MA, Hosseinzadeh M, Kanani ES, et al
   Measurement properties of the Iranian version of the breast cancer perception scale (BCPS) according to the COSMIN checklist.
   BMC Cancer. 2024;24:743.
   

   >> Share

   
   
6. CANINO F, Barbolini M, De Giorgi U, Fontana T, et al
   Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
   BMC Cancer. 2024;24:735.
   

   >> Share

   
   
7. GAULT A, Hogarth L, Williams KC, Greystoke A, et al
   Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study.
   BMC Cancer. 2024;24:733.
   

   >> Share

   
   

   
   Br J Dermatol

8. FISCHER G
   The impact of vulval lichen sclerosus in young people: a call for better awareness, individualised maintenance plans and revised guidelines.
   Br J Dermatol. 2024 Jun 15:ljae254. doi: 10.1093.
   

   >> Share

   
   
9. MCMAHON M, Deacon DC
   Spatial sequencing reveals transcriptional variation between amelanotic and pigmented acral melanoma.
   Br J Dermatol. 2024 Jun 15:ljae253. doi: 10.1093.
   

   >> Share

   
   
10. HASCHE D, Hufbauer M, Braspenning-Wesch I, Stephan S, et al
    Cytokeratin-17 expression is commonly observed in keratinocytic skin tumours and controls tissue homeostasis impacting HPV protein expression.
    Br J Dermatol. 2024 Jun 15:ljae255. doi: 10.1093.
    

    >> Share

    
    
11. THACI D, Pinter A, Sebastian M, Termeer C, et al
    Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naive patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled p
    Br J Dermatol. 2024;191:36-48.
    

    >> Share

    
    
12. SALAMON G, Strobl S, Field-Werners U, Diem A, et al
    Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
    Br J Dermatol. 2024;191:75-81.
    

    >> Share

    
    
13. KEARNEY N, Kirby B
    Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab.
    Br J Dermatol. 2024;191:5-6.
    

    >> Share

    
    
14. LIANG L, Peng S, Huang S, Wang H, et al
    Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib.
    Br J Dermatol. 2024;191:148-149.
    

    >> Share

    
    
15. LIU Y, Liu J, Chen Y, Mo R, et al
    Potential digenic inheritance of SERPINB7 and SERPINA12 variants in Chinese patients with Nagashima-type palmoplantar keratosis.
    Br J Dermatol. 2024;191:136-138.
    

    >> Share

    
    
16. GOLETZ S, Probst C, Komorowski L, Radzimski C, et al
    Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin beta4 subunit.
    Br J Dermatol. 2024;191:140-141.
    

    >> Share

    
    
17. TULL TJ, Benton EC, Semkova K, Watson NA, et al
    Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.
    Br J Dermatol. 2024;191:138-140.
    

    >> Share

    
    
18. DANBY SG
    Debunking the myth that all emollients are equal opens the door for future atopic dermatitis prevention studies.
    Br J Dermatol. 2024;191:6-7.
    

    >> Share

    
    
19. ABDOLRASOULI A, Hay RJ
    Antifungal-resistant Trichophyton indotineae: transmission is occurring outside previously identified endemic areas - are we prepared?
    Br J Dermatol. 2024;191:145-146.
    

    >> Share

    
    
20. HORISSIAN M, Samaan C, Cohrs A, Kirby J, et al
    Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021.
    Br J Dermatol. 2024;191:142-143.
    

    >> Share

    
    
21. XIE W, Kong X, Liu W, Liang G, et al
    Antifungal-resistant Trichophyton indotineae: transmission warrants priority attention and international collaboration.
    Br J Dermatol. 2024;191:146-147.
    

    >> Share

    
    
22. TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
    Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
    Br J Dermatol. 2024;191:143-144.
    

    >> Share

    
    
23. 
    Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis.
    Br J Dermatol. 2024;191:e3.
    

    >> Share

    
    

    
    Cancer Lett

24. WANG J, Fan P, Shen P, Fan C, et al
    XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer.
    Cancer Lett. 2024 Apr 4:216846. doi: 10.1016/j.canlet.2024.216846.
    

    >> Share

    
    
25. LIN Z, Chen L, Wang Y, Zhang T, et al
    Improving Ultrasound Diagnostic Precision for Breast Cancer and Adenosis with Modality-Specific Enhancement (MSE) - Breast Net.
    Cancer Lett. 2024 May 23:216977. doi: 10.1016/j.canlet.2024.216977.
    

    >> Share

    
    
26. LV Y, Sun S, Zhang J, Wang C, et al
    Loss of RBM45 inhibits breast cancer progression by reducing the SUMOylation of IRF7 to promote IFNB1 transcription.
    Cancer Lett. 2024 May 24:216988. doi: 10.1016/j.canlet.2024.216988.
    

    >> Share

    
    
27. LI M, Zhang L, Guan T, Huang L, et al
    Energy stress-activated AMPK phosphorylates Snail1 and suppresses its stability and oncogenic function.
    Cancer Lett. 2024;595:216987.
    

    >> Share

    
    
28. KIM YJ, Lee M, Kim EH, Lee S, et al
    Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study.
    Cancer Lett. 2024;596:216998.
    

    >> Share

    
    
29. FLETCHER K, Cortellini A, Ganta T, Kankaria R, et al
    Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
    Cancer Lett. 2024;596:217001.
    

    >> Share

    
    

    
    Cancer Res

30. OATMAN N, Gawali MV, Congrove S, Caceres R, et al
    A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis.
    Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-23-1635.
    

    >> Share

    
    

    
    Int J Cancer

31. BAO Y, Sui X, Wang X, Qu N, et al
    Extrachromosomal circular DNA landscape of breast cancer with lymph node metastasis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34985.
    

    >> Share

    
    
32. LIN YY, Gao HF, Li H, Hu Q, et al
    Clinical efficacy of tumor organoid-guided cancer therapy for locally advanced unresectable or metastatic breast cancer.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34945.
    

    >> Share

    
    
33. KIM CE, Pereira A, Binder AM, Amarasiriwardena C, et al
    Time-specific impact of trace metals on breast density of adolescent girls in Santiago, Chile.
    Int J Cancer. 2024;155:627-636.
    

    >> Share

    
    
34. FODA BM, Misek SA, Gallo KA, Neubig RR, et al
    Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade.
    Int J Cancer. 2024 Jun 19. doi: 10.1002/ijc.35056.
    

    >> Share

    
    

    
    Int J Dermatol

35. TAYLOR MA, Thomas SI, Ituarte BE, Sharma D, et al
    Racial and ethnic differences in presentation and disease-specific survival in female melanoma patients.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17322.
    

    >> Share

    
    
36. RAU A, Silva GS, Margolis DJ, Chiesa Fuxench ZC, et al
    Adult and infantile seborrheic dermatitis: update on current state of evidence and potential research frontiers.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17324.
    

    >> Share

    
    
37. HUANG P, Wen F, Li Q
    Evidence for a causal relationship between immune cells and cutaneous melanoma: a Mendelian randomization study.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17305.
    

    >> Share

    
    
38. CHHABRA N, Peethambaran AS, Kar BK, Reddy PSM, et al
    Cryptococcosis involving skin and bone in a non-HIV lepromatous leprosy patient with chronic type 2 lepra reaction.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17336.
    

    >> Share

    
    
39. AN I
    Cutaneous findings and treatment responses of lipoid proteinosis patients.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17331.
    

    >> Share

    
    
40. MAHAJAN R, Baskaran N, Kumar S, Behera B, et al
    Creating the Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL) Cutaneous Rare Disease Registry (I-CuReD): a 1-year experience.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17315.
    

    >> Share

    
    
41. CHOE SI, Taylor MA, Griffin JB, Silberstein PT, et al
    Comparison of disease-specific survival in penile melanoma versus other cutaneous sites: a SEER national database study.
    Int J Dermatol. 2024 Jun 14. doi: 10.1111/ijd.17337.
    

    >> Share

    
    
42. DANISH M, Khandpur S, Khanna N, Bhari N, et al
    A randomized trial comparing 308 nm excimer light with PUVA soak therapy for palmoplantar psoriasis.
    Int J Dermatol. 2024 Jun 16. doi: 10.1111/ijd.17328.
    

    >> Share

    
    
43. MILLAN IV, Fernandez Canedo I, Lopez-Cozar PG, Liebana RF, et al
    Presurgical delimitation with tape skin markers and ex vivo ultrasound study of in transit melanoma metastases.
    Int J Dermatol. 2024 Jun 17. doi: 10.1111/ijd.17329.
    

    >> Share

    
    
44. SAH B, Singh J, Shen Y, Goldfarb N, et al
    Loss of CELF2 promotes skin tumorigenesis and increases drug resistance.
    Int J Dermatol. 2024 Jun 17. doi: 10.1111/ijd.17295.
    

    >> Share

    
    

    
    Intern Med

45. FUKUSHIMA K, Yoshida T, Yamazaki H, Takamatsu N, et al
    A Case of Anti-NXP2 Antibody-positive Juvenile Dermatomyositis with Characteristic Fascial Thickening on Muscle Ultrasound and Improvement with Immunotherapy.
    Intern Med. 2023 Nov 6. doi: 10.2169/internalmedicine.2720.
    

    >> Share

    
    
46. TATSUMI H, Nunokawa T, Chinen N
    Occipital Artery Involvement in Giant Cell Arteritis.
    Intern Med. 2023 Nov 6. doi: 10.2169/internalmedicine.2745.
    

    >> Share

    
    

    
    J Cutan Pathol

47. TSENG C, Hein ECK, Smith SM, King I, et al
    Ulcerated CRTC1::TRIM11 cutaneous tumor with metastases.
    J Cutan Pathol. 2024 Jun 15. doi: 10.1111/cup.14669.
    

    >> Share

    
    

    
    J Dermatol

48. MITSUYAMA S, Higuchi T, Nabekura T, Wakamatsu K, et al
    Improvement of psoriasis vulgaris in a patient with obesity after bariatric and metabolic surgery: A case letter.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17342.
    

    >> Share

    
    
49. ITO K, Akatsuka T, Morimura S, Hamada T, et al
    Primary cutaneous follicle center lymphoma localized on the back for 22 years.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17345.
    

    >> Share

    
    
50. TSAI YY, Chen YJ, Chang LS, Wu CC, et al
    Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted alpha-toxin on filaggrin expression.
    J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17326.
    

    >> Share

    
    
51. LIN F, Wang Y, Zheng Y, Hong W, et al
    Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: A retrospective study.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17320.
    

    >> Share

    
    
52. FAN H, Yan L, Tan Y, Feng J, et al
    Bevacizumab-associated toxic epidermal necrolysis in a patient with liver cancer.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17285.
    

    >> Share

    
    
53. KIRATIKANON S, Maneenut A, Noppakun N, Kumtornrut C, et al
    Effects of spironolactone on skin biophysical properties in women with acne treated with oral spironolactone.
    J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17333.
    

    >> Share

    
    

    
    J Invest Dermatol

54. TILIGADA E, Levi-Schaffer F
    Infiltrating Basophils Tune Injured Skin Barrier Recovery.
    J Invest Dermatol. 2024 Jun 14:S0022-202X(24)00438.
    

    >> Share

    
    
55. MA X, Zhao H, Song JK, Zhang Z, et al
    Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.
    J Invest Dermatol. 2024 Jun 13:S0022-202X(24)01735.
    

    >> Share

    
    
56. BAO L, Perez White BE, Chang RC, Li J, et al
    FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents.
    J Invest Dermatol. 2024 Jun 15:S0022-202X(24)01504.
    

    >> Share

    
    
57. CVAMMEN W, Rider SD Jr, Kemp MG
    Analysis of circadian clock gene expression in epidermal human skin indicates that body location impacts rhythm amplitude.
    J Invest Dermatol. 2024 Jun 15:S0022-202X(24)01497.
    

    >> Share

    
    
58. PEREDA J, Milde Khatib C, Kezic S, Christensen MO, et al
    A Review of Atomic-Force Microscopy in Skin Barrier Function Assessment.
    J Invest Dermatol. 2024 Jun 18:S0022-202X(24)00357.
    

    >> Share

    
    
59. OLSEN CM, Pandeya N, Miranda-Filho A, Rosenberg PS, et al
    Does sex matter? Temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity.
    J Invest Dermatol. 2024 Jun 17:S0022-202X(24)01500.
    

    >> Share

    
    
60. KAO YC, Stark MS
    Challenging the Lymph Node Progression Model of Melanoma.
    J Invest Dermatol. 2024 Jun 20:S0022-202X(24)00385.
    

    >> Share

    
    
61. GANIER C, Callewaert C, Matos TR, Sonkoly E, et al
    Young ESDR: Engaging and Nurturing the Next-Generation Skin Research Community.
    J Invest Dermatol. 2024 Jun 19:S0022-202X(24)00382.
    

    >> Share

    
    

    
    Mycoses

62. LI J, Zhi H, Xia X, Liu Z, et al
    A survey of 701 cases of tinea faciei in Hangzhou, southeastern China, from 2018 to 2023.
    Mycoses. 2024;67:e13755.
    

    >> Share

    
    
63. KHIEWPLUEANG K, Leeyaphan C, Bunyaratavej S, Jirawattanadon P, et al
    Tinea faciei clinical characteristics, causative agents, treatments and outcomes; a retrospective study in Thailand.
    Mycoses. 2024;67:e13754.
    

    >> Share

    
    
64. SHAHABUDIN S, Azmi NS, Lani MN, Mukhtar M, et al
    Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management.
    Mycoses. 2024;67:e13753.
    

    >> Share

    
    

    
    N Engl J Med

65. LONG GV, Hauschild A, Santinami M, Kirkwood JM, et al
    Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
    N Engl J Med. 2024 Jun 19. doi: 10.1056/NEJMoa2404139.
    

    >> Share

    
    
66. ROY N, Mandal M
    Insulin-Induced Lipohypertrophy.
    N Engl J Med. 2024;390:e60.
    

    >> Share

    
    
67. JORGE AM, Ard KL, Turbett SE
    Case 19-2024: A 46-Year-Old Man with Arthritis and Rash.
    N Engl J Med. 2024;390:2200-2207.
    

    >> Share

    
    
68. TU H, Zhang Y, You Z
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2219-2220.
    

    >> Share

    
    
69. LI Q, Cai Y, Li J
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2220.
    

    >> Share

    
    
70. TANNOCK IF, Meirson T, Fojo A
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2220-2221.
    

    >> Share

    
    
71. SLAMON D, Yardley DA, Hortobagyi G
    Ribociclib plus Endocrine Therapy in Early Breast Cancer. Reply.
    N Engl J Med. 2024;390:2221-2222.
    

    >> Share

    
    

    
    PLoS Biol

72. HOU X, Ouyang J, Tang L, Wu P, et al
    KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation.
    PLoS Biol. 2024;22:e3002666.
    

    >> Share

    
    

    
    PLoS One

73. TUTUIANU A, Anene CA, Shelton M, Speirs V, et al
    Platelet-derived microvesicles isolated from type-2 diabetes mellitus patients harbour an altered miRNA signature and drive MDA-MB-231 triple-negative breast cancer cell invasion.
    PLoS One. 2024;19:e0304870.
    

    >> Share

    
    
74. OSSAI EN, Ekeke N, Esmai-Onyima A, Eze C, et al
    Understanding the burden of poor mental health and wellbeing among persons affected by leprosy or Buruli ulcer in Nigeria: A community based cross-sectional study.
    PLoS One. 2024;19:e0304786.
    

    >> Share

    
    
75. DAVIDOVIC M, Dhokotera T, Dos-Santos-Silva I, Bohlius J, et al
    Breast cancer in women by HIV status: A report from the South African National Cancer Registry.
    PLoS One. 2024;19:e0305274.
    

    >> Share

    
    
76. LI X, Jiang X, Gao F, Zhou L, et al
    Study and evaluation of a gelatin- silver oxide nanoparticles releasing nitric oxide production of wound healing dressing for diabetic ulcer.
    PLoS One. 2024;19:e0298124.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share